Interleukin-12 as an inducer of cytotoxic effectors in anti-tumor immunity

Int Rev Immunol. 1997;14(2-3):229-56. doi: 10.3109/08830189709116854.

Authors

K Kumagai¹, K Takeda, W Hashimoto, S Seki, K Ogasawara, R Anzai, M Takahashi, M Sato, H Rikiishi

Affiliation

¹ Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

PMID: 9131389
DOI: 10.3109/08830189709116854

No abstract available

Publication types

Review

MeSH terms

Animals
Humans
Interleukin-12 / therapeutic use*
Killer Cells, Lymphokine-Activated / drug effects
Killer Cells, Lymphokine-Activated / immunology
Killer Cells, Natural / drug effects
Killer Cells, Natural / immunology
Neoplasm Metastasis / prevention & control
Neoplasms / immunology
Neoplasms / therapy*
Receptors, Interleukin / physiology
Receptors, Interleukin-12
T-Lymphocytes, Cytotoxic / drug effects
T-Lymphocytes, Cytotoxic / immunology
Th1 Cells / drug effects
Th1 Cells / immunology

Substances

Receptors, Interleukin
Receptors, Interleukin-12
Interleukin-12